Perhaps the bears were onto something with Immuron, the Australian and Nasdaq-listed biopharmaceutical company developing a treatment for diarrhoea.
Yesterday, the US-listed stock collapsed 30pc to close $6.90.
And Immuron's American shares are down another 5pc or so in the pre-market.....
First Immuron; now Jiayin Group.
The US-listed Chinese digital marketplace is in focus after it leapt over 800pc during intraday trading yesterday, rising from $2.9 to an intrday high of $29.
The stock eventually closed at $5.8.
And today the company just announced its first quarter figures (the the link below):..
It's not often a stock jumps a 1000pc in day. But yesterday Immuron, an Australian biopharmaceutical company that trades on Nasdaq, did exactly that on hopes it may develop a new treatment for diarrhoea.
Yes folks you read that correctly - diarrhoea...